These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12205653)

  • 1. Impaired chemosensitivity to hypoxia is a marker of multiple system atrophy.
    Tsuda T; Onodera H; Okabe S; Kikuchi Y; Itoyama Y
    Ann Neurol; 2002 Sep; 52(3):367-71. PubMed ID: 12205653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Diagnosis and Natural History of Multiple System Atrophy, Cerebellar Type.
    Lin DJ; Hermann KL; Schmahmann JD
    Cerebellum; 2016 Dec; 15(6):663-679. PubMed ID: 26467153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expanding concept of clinical conditions and symptoms in multiple system atrophy].
    Watanabe H; Riku Y; Nakamura T; Hara K; Ito M; Hirayama M; Yoshida M; Katsuno M; Sobue G
    Rinsho Shinkeigaku; 2016 Jul; 56(7):457-64. PubMed ID: 27356737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia.
    Kanazawa M; Tada M; Onodera O; Takahashi H; Nishizawa M; Shimohata T
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1149-51. PubMed ID: 23916652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF analysis differentiates multiple-system atrophy from idiopathic late-onset cerebellar ataxia.
    Abdo WF; van de Warrenburg BP; Munneke M; van Geel WJ; Bloem BR; Kremer HP; Verbeek MM
    Neurology; 2006 Aug; 67(3):474-9. PubMed ID: 16894110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic cerebellar ataxia (IDCA): Diagnostic criteria and clinical analyses of 63 Japanese patients.
    Yoshida K; Kuwabara S; Nakamura K; Abe R; Matsushima A; Beppu M; Yamanaka Y; Takahashi Y; Sasaki H; Mizusawa H;
    J Neurol Sci; 2018 Jan; 384():30-35. PubMed ID: 29249373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonidine GH stimulation test to differentiate MSA from idiopathic late onset cerebellar ataxia: a prospective, controlled study.
    Bonnard C; Wirth T; Gebus O; Fahrer P; Montaut S; Robelin L; Tuzin N; Tranchant C; Anheim M
    J Neurol; 2020 Mar; 267(3):855-859. PubMed ID: 32034477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson's disease and idiopathic late-onset cerebellar ataxia.
    Pellecchia MT; Pivonello R; Salvatore E; Faggiano A; Barone P; De Michele G; Lombardi G; Colao A; Filla A
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):428-33. PubMed ID: 15807873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple system atrophy of the cerebellar type: clinical state of the art.
    Lin DJ; Hermann KL; Schmahmann JD
    Mov Disord; 2014 Mar; 29(3):294-304. PubMed ID: 24615754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Phalanx sign" helps to discriminate MSA-C from idiopathic late onset cerebellar ataxia.
    Schneider V; Wirth T; Iosif A; Montaut S; Lagha-Boukbiza O; Tranchant C; Anheim M
    J Neurol; 2022 Jul; 269(7):3900-3903. PubMed ID: 35147729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI-based volumetric differentiation of sporadic cerebellar ataxia.
    Burk K; Globas C; Wahl T; Bühring U; Dietz K; Zuhlke C; Luft A; Schulz JB; Voigt K; Dichgans J
    Brain; 2004 Jan; 127(Pt 1):175-81. PubMed ID: 14570820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry.
    Köllensperger M; Geser F; Ndayisaba JP; Boesch S; Seppi K; Ostergaard K; Dupont E; Cardozo A; Tolosa E; Abele M; Klockgether T; Yekhlef F; Tison F; Daniels C; Deuschl G; Coelho M; Sampaio C; Bozi M; Quinn N; Schrag A; Mathias CJ; Fowler C; Nilsson CF; Widner H; Schimke N; Oertel W; Del Sorbo F; Albanese A; Pellecchia MT; Barone P; Djaldetti R; Colosimo C; Meco G; Gonzalez-Mandly A; Berciano J; Gurevich T; Giladi N; Galitzky M; Rascol O; Kamm C; Gasser T; Siebert U; Poewe W; Wenning GK;
    Mov Disord; 2010 Nov; 25(15):2604-12. PubMed ID: 20922810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of multiple system atrophy in the USA: a prospective cohort study.
    Low PA; Reich SG; Jankovic J; Shults CW; Stern MB; Novak P; Tanner CM; Gilman S; Marshall FJ; Wooten F; Racette B; Chelimsky T; Singer W; Sletten DM; Sandroni P; Mandrekar J
    Lancet Neurol; 2015 Jul; 14(7):710-9. PubMed ID: 26025783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of sporadic olivopontocerebellar atrophy into multiple system atrophy.
    Gilman S; Little R; Johanns J; Heumann M; Kluin KJ; Junck L; Koeppe RA; An H
    Neurology; 2000 Aug; 55(4):527-32. PubMed ID: 10953186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arginine test is not reliable for diagnosing cerebellar multiple system atrophy.
    Gardner RC; Schmahmann JD
    Ann Neurol; 2010 Mar; 67(3):404-8. PubMed ID: 20373353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MSA-C is the predominant clinical phenotype of MSA in Japan: analysis of 142 patients with probable MSA.
    Yabe I; Soma H; Takei A; Fujiki N; Yanagihara T; Sasaki H
    J Neurol Sci; 2006 Nov; 249(2):115-21. PubMed ID: 16828805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventilatory and cardiovascular responses to hypercapnia and hypoxia in multiple-system atrophy.
    Lipp A; Schmelzer JD; Low PA; Johnson BD; Benarroch EE
    Arch Neurol; 2010 Feb; 67(2):211-6. PubMed ID: 20142529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sporadic Cerebellar Ataxia: Multiple System Atrophy and Mono System Atrophy].
    Watanabe H; Ito M; Mizutani Y; Ueda A; Shima S
    Brain Nerve; 2020 Sep; 72(9):931-937. PubMed ID: 32934182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinguishing spinocerebellar ataxia with pure cerebellar manifestation from multiple system atrophy (MSA-C) through saccade profiles.
    Terao Y; Fukuda H; Tokushige SI; Inomata-Terada S; Yugeta A; Hamada M; Ugawa Y
    Clin Neurophysiol; 2017 Jan; 128(1):31-43. PubMed ID: 27866117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy.
    Schulz JB; Skalej M; Wedekind D; Luft AR; Abele M; Voigt K; Dichgans J; Klockgether T
    Ann Neurol; 1999 Jan; 45(1):65-74. PubMed ID: 9894879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.